PREETI SODHI: Open Payments
NPI 1033268065 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 47 payments from 7 companies in 2025. Trend: 2023 $374 · 2024 $1,092 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $235 |
| Otsuka America Pharmaceutical, Inc. | 18 | $218 |
| Supernus Pharmaceuticals, Inc. | 1 | $111 |
| Teva Pharmaceuticals USA, Inc. | 5 | $92 |
| Janssen Pharmaceuticals, Inc | 4 | $87 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Lundbeck LLC | 3 | $45 |
Products named: CAPLYTA, REXULTI, Qelbree, UZEDY, INVEGA SUSTENNA, COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA.
Industry payments across TX — which companies pay providers there.
